Biotech-informed skincare collaborations are moving beyond generic formulations to personalize interventions based on bioactive compounds and mechanistic pathways, mirroring shifts seen in recent industry–academia partnerships.
This trend aligns with broader anti-aging research that targets upstream drivers—senescence, inflammation, and impaired recycling—rather than masking downstream signs.